PuraPharm Corporation Limited reported an unchanged authorized share capital of 5,000.00 billion ordinary shares at a par value of USD 0.001 each, amounting to USD 5.00 billion. As of 28 February 2026, the total issued share count remained at 535.90 million, with no treasury shares in issue.

Public float requirements were met as required by relevant regulations. Under the share option scheme, 23.96 million share options remained outstanding at the end of February 2026, and no additional new shares were issued. The documentation confirms no change in treasury shares or other agreements involving the issuance of shares during the reporting period.